SCHEMBL4772107

SCHEMBL4772107

COc1ccc(C(Cc2cnc(Nc3ccccc3)nc2Nc2ccccc2)C(=O)O)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.57
MAPK9 P45984 1/20 0.57
ULK1 O75385 1/20 0.45
EGFR P00533 7/20 0.45
ITK Q08881 3/20 0.45
JAK3 P52333 2/20 0.44
SYK P43405 4/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
PTK2 Q05397 1/20 0.43
AURKA O14965 1/20 0.42
BTK Q06187 4/20 0.42
MAP4K1 Q92918 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
BRD4 O60885 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767520 0.91 MAPK8 (0.54) MAPK8MAPK9ULK1EGFRITK
SCHEMBL4774864 0.87 CHEK1 (0.50) MAPK8MAPK9EGFRITKJAK3
SCHEMBL4766694 0.86 SYK (0.50) MAPK8MAPK9EGFRITKJAK3
SCHEMBL4773873 0.86 MAPK8 (0.51) MAPK8MAPK9ULK1EGFRITK
SCHEMBL4770594 0.85 MAPK9 (0.51) MAPK8MAPK9ULK1EGFRITK
SCHEMBL4775386 0.84 AURKA (0.49) MAPK8MAPK9EGFRITKJAK3
SCHEMBL4771570 0.81 MAPK8 (0.50) MAPK8MAPK9ULK1EGFRITK
SCHEMBL4771624 0.81 CHEK1 (0.46) MAPK8MAPK9EGFRITKSYK
SCHEMBL4772172 0.80 GSK3B (0.51) MAPK8MAPK9EGFRITKJAK3
SCHEMBL4769925 0.80 AURKA (0.48) MAPK8MAPK9EGFRITKJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581531-B1 PYRIDINO¬2,3-D PYRIMIDINE DERIVATIVES AS SELECTIIVE KDR AND FGFR INHIBITORS HOFFMANN LA ROCHE (CH) 2008-02-27 EP claimed